Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase
暂无分享,去创建一个
Albert J. Fornace | Ettore Appella | Hiroshi Yamaguchi | E. Appella | A. Fornace | H. Yamaguchi | S. Shreeram | O. Demidov | Weng Kee Hee | C. Kek | C. Anderson | D. Bulavin | Oleg N. Demidov | Dmitry V. Bulavin | Carl W. Anderson | Sathyavageeswaran Shreeram | Calvina Kek | Calvina Kek
[1] Francis Collins,et al. Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia , 1996, Cell.
[2] Albert J. Fornace,et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.
[3] Jeffrey R. Marks,et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 , 2002, Nature Genetics.
[4] E. Hölttä,et al. Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases , 2000, Oncogene.
[5] M. Lavin,et al. Involvement of novel autophosphorylation sites in ATM activation , 2006, The EMBO journal.
[6] L. Donehower,et al. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. , 2005, Genes & development.
[7] Dahai Zhu,et al. ATM activity contributes to the tumor-suppressing functions of p14ARF , 2004, Oncogene.
[8] K. Khanna,et al. Autophosphorylation of ataxia‐telangiectasia mutated is regulated by protein phosphatase 2A , 2004, The EMBO journal.
[9] S. Jackson,et al. Cleavage and Inactivation of ATM during Apoptosis , 1999, Molecular and Cellular Biology.
[10] T. Ørntoft,et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.
[11] R. Palmiter,et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.
[12] E. Appella,et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. , 2006, Molecular cell.
[13] S. Lowe,et al. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. , 1999, Genes & development.
[14] L. Donehower,et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathway , 2004, Nature Genetics.
[15] Jiri Bartek,et al. Cell-cycle checkpoints and cancer , 2004, Nature.
[16] Y. Shiloh,et al. ATM: genome stability, neuronal development, and cancer cross paths. , 2001, Advances in cancer research.
[17] John T. Powers,et al. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. , 2004, Molecular cancer research : MCR.
[18] E. Brambilla,et al. p14ARF Activates a Tip60-Dependent and p53-Independent ATM/ATR/CHK Pathway in Response to Genotoxic Stress , 2006, Molecular and Cellular Biology.
[19] P. Bouillet,et al. Bim is a suppressor of Myc-induced mouse B cell leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] N. Gueven,et al. ATP Activates Ataxia-Telangiectasia Mutated (ATM) in Vitro , 2003, The Journal of Biological Chemistry.
[21] Michel C. Nussenzweig,et al. Role of genomic instability and p53 in AID-induced c-myc–Igh translocations , 2006, Nature.
[22] Masaaki Adachi,et al. p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.
[23] S. Durell,et al. Substrate Specificity of the Human Protein Phosphatase 2Cδ, Wip1† , 2005 .
[24] N. Onishi,et al. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase , 2006, Cell Death and Differentiation.
[25] A. Nussenzweig,et al. Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo , 2006, Nature.
[26] M. Roussel,et al. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. , 1999, Genes & development.